DNM1 and cancer: The significance of TfR in targeted cancer therapy is supported by several factors: (i) overexpression by cancer cells, (ii) cell surface accessibility promoted by clathrin/dynamin dependent endocytosis [31], and (iii) an essential role in cell growth and proliferation.